MRI Guided Drug Delivery Market to Grow at 11.1% CAGR Through 2032 According to a newly published market research report by 24LifeSciences, global MRI Guided Drug Delivery market was valued at USD 103 million in 2024 and is projected to reach USD 212 million by 2032, growing at a compound annual growth rate (CAGR) of 11.1% during the forecast period 2025-2032. MRI guided drug delivery represents a transformative approach in precision medicine, utilizing magnetic resonance imaging to precisely target and release therapeutic agents at specific anatomical sites. This advanced technology combines real-time imaging with controlled drug release mechanisms, primarily leveraging High-Intensity Focused Ultrasound (HIFU) for non-invasive tissue ablation and targeted therapeutic delivery. The system enables temperature-sensitive drug carriers to release payloads when heated by focused ultrasound beams, while MRI provides continuous anatomical guidance and thermal monitoring, revolutionizing treatment approaches across multiple therapeutic areas. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/2152/mri-guided-drug-delivery-market

Bookmarking sites are online platforms where users save, organize, and manage links to useful webpages. Popular examples include Reddit, Pinterest, and Digg. They help people quickly access favorite websites and discover new content shared by other users. web: https://bit.ly/4sRPWtM

Global Salt Anticaking Agents Market to Reach $989M by 2034 on Processed Food Surge Salt anticaking agents are essential additives designed to prevent the clumping of salt crystals in environments with varying humidity levels. These compounds work through mechanisms such as moisture absorption, surface coating of salt particles, or crystal modification, ensuring free-flowing properties that are vital during packaging, transportation, and end-use. Commonly used agents include sodium ferrocyanide (yellow prussiate of soda), potassium ferrocyanide, calcium silicate, silicon dioxide (silica), and ammonium ferric citrate, each selected based on specific application requirements. Get Full Report Here: https://www.24chemicalresearch.com/reports/306483/salt-anticaking-agent-market

Global Pomace Market Grows 40% to USD 278M on Circular Economy Push Dried Apple Pomace, the fibrous residue remaining after apples are pressed for juice or cider, has evolved from a mere by-product into a valuable commodity within the circular economy. This material is rich in dietary fiber, pectin, and residual nutrients that make it an excellent ingredient for animal feed, organic fertilizers, and even emerging applications in food and biofuels. While its primary use remains in livestock nutrition, recent innovations in processing technologies and sustainability initiatives are unlocking new potential, positioning it as a versatile resource for multiple industries seeking eco-friendly raw materials. Get Full Report Here: https://www.24chemicalresearch.com/reports/306694/dried-apple-pomace-market

Is North America's 40% share powering Fine Art Paints to USD 5.08 B ? Acrylics dominate demand. Global professional fine art paints market size was valued at USD 3.15 billion in 2025. The market is projected to grow from an estimated USD 3.38 billion in 2026 to USD 5.08 billion by 2034, exhibiting a CAGR of 7.3% during the forecast period. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/306174/fine-art-paints-market

Global Aminopyrine API Market Forecast 2026: Revenue Insights According to a newly published market research report by 24LifeSciences, global Aminopyrine API market was valued at USD 28.85 million in 2025 and is projected to reach USD 25.64 million by 2032, declining at a compound annual growth rate (CAGR) of -1.8% during the forecast period 2026-2032. Aminopyrine, a pyrazolone-derivative compound, is a non-narcotic analgesic and antipyretic API historically used to treat pain and fever, particularly associated with rheumatic conditions. However, its application is now severely limited due to its well-documented risk of causing agranulocytosis, a potentially fatal blood disorder. Consequently, its use in human medicine has been banned or heavily restricted across most developed markets, confining its legal application to a few specific geographic regions and non-therapeutic uses. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/12658/aminopyrine-api-market